<?xml version="1.0" encoding="UTF-8"?>
<ref id="B141-molecules-23-01531" class="ref">
 <label class="label">141.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Yakunin</surname>
    <given-names class="given-names">E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Loeb</surname>
    <given-names class="given-names">V.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kisos</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Biala</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yehuda</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yaari</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Selkoe</surname>
    <given-names class="given-names">D.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sharon</surname>
    <given-names class="given-names">R.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Î±-Synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease</article-title>
  <source class="source">Brain Pathol.</source>
  <year class="year">2012</year>
  <volume class="volume">22</volume>
  <fpage class="fpage">280</fpage>
  <lpage class="lpage">294</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1111/j.1750-3639.2011.00530.x</pub-id>
  <?supplied-pmid 21929559?>
  <pub-id pub-id-type="pmid" class="pub-id">21929559</pub-id>
 </element-citation>
</ref>
